Inari Medical partners with AVF, NBCA on DEFIANCE trial

In recognition of World Thrombosis Day, Inari Medical announced collaborative partnerships with the American Venous Forum and the National Blood Clot Alliance on the DEFIANCE trial. This prospective, multinational, randomized controlled trial will evaluate and compare clinical outcomes in patients with deep vein thrombosis treated with Inari’s ClotTriever System versus anticoagulation alone. AVF is a non-profit society dedicated to improving the care of patients with venous and lymphatic disease, with members and leadership recognized internationally as thought leaders, expert investigators and top clinicians in the field. NBCA is the leading non-profit in the United States focused on building awareness and community among people who are affected by blood clots.